FDA Inspection
Qilu Antibiotics Pharmaceutical Co. , Ltd.Qilu Antibiotics Pharmaceutical Co. , Ltd. – FDA Inspection, Aug 16, 2018
Record Details
This FDA Inspection record concerns Qilu Antibiotics Pharmaceutical Co. , Ltd., with an inspection on August 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3c041f5a-2a6c-4c99-8b5b-11e9ce5a735c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1067678
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Qilu Antibiotics Pharmaceutical Co. , Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2026 | Not classified | Office of Inspections and Investigations | |
| May 30, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Antibiotics Pharmaceutical Co. , Ltd.
- FDA Inspection 1333262 - 2026-07-16
- FDA Inspection 1210065 - 2023-05-30
- FDA Inspection 945452 - 2015-09-22
- FDA Inspection 851836 - 2013-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.